EPILIM

This brand name is authorized in Australia, Hong Kong, Ireland, Malta, Nigeria, New Zealand, Singapore, United Kingdom, South Africa

Active ingredients

The drug EPILIM contains one active pharmaceutical ingredient (API):

1 Valproic acid UNII 5VOM6GYJ0D - VALPROATE SODIUM

Valproic acid is anti-convulsant. The most likely mode of action for valproate is potentiation of the inhibitory action of gamma amino butyric acid (GABA) through an action on the further synthesis or further metabolism of GABA. Read about Valproic acid

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
EPILIM Powder and solvent for solution for injection / infusion	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N03AG01	Valproic acid	N Nervous system → N03 Antiepileptics → N03A Antiepileptics → N03AG Fatty acid derivatives
Discover more medicines within N03AG01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 2289L, 2290M, 2293Q, 2294R, 2295T
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 161727, 22255, 22276, 364423, 364425, 364427, 43513
Country: HK	Department of Health Drug Office	Identifier(s): 27293, 27300, 31199, 38257
Country: IE	Health Products Regulatory Authority	Identifier(s): 23503, 23516, 23524, 23531, 23665, 23666, 23736, 37041, 37042, 37043
Country: MT	Medicines Authority	Identifier(s): MA1359/01903, MA1359/01904
Country: NG	Registered Drug Product Database	Identifier(s): 04-1834
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 2216, 2217, 2219, 2220, 2221, 2223
Country: SG	Health Sciences Authority	Identifier(s): 05215P, 05434P, 05690P
Country: ZA	Health Products Regulatory Authority	Identifier(s): 27/2.5/0322, 27/2.5/0323, 27/2.5/0500, A38/2.5/0637, J/2.5/148, Y/2.5/286, Y/2.5/43